Address: Dandyvej 19, DK-7100 Vejle, Denmark
Tel: +45 7215 1300
Web: fertin.com
Fertin Pharma aims to be one of the leading suppliers of selected medical dispensation forms within relevant therapeutic areas.Fertin Pharma is a world leader in the development and manufacture of medical chewing gum. Our largest product category is smoking cessation chewing gum.
Our largest product category is smoking cessation chewing gum.
Erik Jylling of the Danish Regions, the organisation charged with healthcare management for each of Denmark’s five regions, outlines the advantages and challenges which persist within Danish healthcare and sounds…
Data has been collected within Danish healthcare for more than 40 years, extending beyond the national patient registry to include a broad range of data points, from IVF to the…
Copenhagen Capacity is Greater Copenhagen’s official organization for investment, promotion, and business development. Its CEO/managing director, Asbjørn Overgaard, outlines the fundamentals attracting life sciences firms to the region, stakeholders’ key…
Danish pharma industry veteran Peter Drøidal highlights how he steered the Danish Novartis affiliate through the COVID-19 pandemic period, the strategy in place to navigate an increasingly challenging market access…
Peter Huntley of Medicoindustrien, the industry association for Danish medtech, outlines his vision for the industry, including why a shift to broad, value-based pricing will better establish Denmark as a…
Per Jørgensen, deputy director of Copenhagen University Hospital (Rigshospitalet), discusses pandemic management, clinical trial collaborations with private industry, translational research, and the demands that the hospitals of the future will…
Petter Hartman of the Medicon Valley Alliance, a non-profit membership organisation spanning the Danish-Swedish life science cluster Medicon Valley, introduces the progress of the Alliance from a networking body to…
Since joining Danish neuroscience specialist Lundbeck as its global CEO in 2018, South African Deborah Dunsire has focused on “revitalising and refreshing” the firm’s pipeline, which had seen several failures…
Speaking exclusively to PharmaBoardroom, Lundbeck’s global CEO Deborah Dunsire describes the progress in the strategy she put in place to “revitalise and refresh” the Danish firm’s pipeline upon taking the…
Industry veteran Patrik Forsell oversees Takeda’s operations in Denmark. Here, Forsell talks through how sizeable shifts in the company’s global portfolio and focus over the past four years have played…
In a wide-ranging interview, AbbVie’s Linn Mandahl discusses how the reorganisation of Scandinavian operations back in 2018 has put the company back on a growth trajectory in the region. Mandahl…
Long established as a premier early launch country for innovative medicines within Europe, the Danish market access system has become more complicated of late as the Danish Medicines Council –…
See our Cookie Privacy Policy Here
